Figure 1
The NeoAva study design. Patients included in the study were randomized to receive chemotherapy with or without bevacizumab.
Figure 1 | Scientific Reports
The NeoAva study design. Patients included in the study were randomized to receive chemotherapy with or without bevacizumab.
